PT  - JOURNAL ARTICLE
ED  - ,
TI  - Correction: Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept
AID  - 10.1136/jitc-2022-004699corr1
DP  - 2022 May 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e004699corr1
VI  - 10
IP  - 5
4099  - http://jitc.bmj.com/content/10/5/e004699corr1.short
4100  - http://jitc.bmj.com/content/10/5/e004699corr1.full
SO  - J Immunother Cancer2022 May 01; 10